Greenoaks led a $75m Series A round in David.

Greenoaks, an investment firm, led a $75m Series A round in David, a brand that designs tools to increase muscle and decrease fat, with participation from Valor Equity Partners. “Our mission is simple: to remove unnecessary calories and sugar from the American diet and replace them with what the body actually needs, which is high-quality protein. We’re building tools that make it easier to eat well without compromise. The response to David has been overwhelming, and this funding allows us to scale faster and stay focused on our mission of providing solutions to support and improve people’s health and well-being ,” Peter Rahal, David Co-Founder and CEO.